Annual Drug Patent Expirations for ZILBRYSQ
Zilbrysq is a drug marketed by Ucb Inc and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
This drug has one hundred and one patent family members in twenty-eight countries.
The generic ingredient in ZILBRYSQ is zilucoplan sodium. One supplier is listed for this compound. Additional details are available on the zilucoplan sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com